GE HealthCare Technologies (GEHC) Gross Margin (2022 - 2026)
GE HealthCare Technologies (GEHC) reported Gross Margin of 38.53% for Q1 2026, down 359.0% on a YoY basis from 14.88% in Q1 2025, and down 2.9% quarter-over-quarter from 39.68% in Q4 2025.
GE HealthCare Technologies (GEHC) Gross Margin (2022 - 2026) Analysis & Trends
GE HealthCare Technologies has reported Gross Margin for 5 years, with the latest figure at 38.53% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 359.0% year-over-year to 38.53%; the trailing twelve-month figure through Mar 2026 stood at 39.15% (down 285.0% YoY), and the FY2025 full-year result was 39.99%, down 172.0% from the prior year.
- Gross Margin for Q1 2026 stood at 38.53%, down from 39.68% in the prior quarter.
- The five-year high for Gross Margin was 42.77% in Q4 2024, with the low at 38.53% in Q1 2026.
- Historically, Gross Margin has averaged 40.23% across 5 years, with a median of 40.13% in 2023.
- Annual changes were most pronounced in 2023 — Gross Margin jumped 229 bps — and 2026, when it plunged 359 bps.
- GE HealthCare Technologies' Gross Margin stood at 39.13% in 2022, then increased by 6 bps to 41.41% in 2023, then advanced by 3 bps to 42.77% in 2024, then declined by 7 bps to 39.68% in 2025, then declined by 3 bps to 38.53% in 2026.
- The last three Gross Margin figures came in at 38.53% (Q1 2026), 39.68% (Q4 2025), and 38.69% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 78.01% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 38.53% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 62.95% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 43.89% |
| 10 | Zimmer Biomet Holdings | 17.27 Bn | 16.86 Bn | 1.51 Bn | 72.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.53% |
| Dec 31, 2025 | 39.68% |
| Sep 30, 2025 | 38.69% |
| Jun 30, 2025 | 39.64% |
| Mar 31, 2025 | 42.12% |
| Dec 31, 2024 | 42.77% |
| Sep 30, 2024 | 41.66% |
| Jun 30, 2024 | 41.37% |
| Mar 31, 2024 | 40.90% |
| Dec 31, 2023 | 41.41% |
| Sep 30, 2023 | 40.13% |
| Jun 30, 2023 | 40.27% |
| Mar 31, 2023 | 40.17% |
| Dec 31, 2022 | 39.13% |
| Sep 30, 2022 | 38.75% |
| Jun 30, 2022 | 40.05% |
| Mar 31, 2022 | 38.64% |